MedPath

RYBELSUS

RYBELSUS

Approved
DIN Number

02551020

Drug Class

Human

Market Date

N/A

Company
HC

Novo Nordisk Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02551020
AIG Number0159870012
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
A10BJ06 SEMAGLUTIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.06
Health Canada Classification

ACTIVE INGREDIENTS (1)

SEMAGLUTIDEActive
Strength: 4 MG
Monograph: SEMAGLUTIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.